...81.5% positive percent agreement and 100% negative percent agreement with a tumor tissue-based test from Qiagen N.V....

...market, with a market cap above $6 billion.Qiagen N.V....

...molecular diagnostics, is a veteran of Novartis AG (NYSE:NVS; SIX:NOVN), Myriad Genetics Inc. (NASDAQ:MYGN) and Qiagen N.V....

...yield enough antibodies to start Phase I testing.Qiagen...
...antibody and antigen tests to be run simultaneously.Qiagen...
...Research Institute of Epidemiology and Microbiology Pfizer Inc. Ellume Ltd. Qiagen N.V. Moderna...

...By Elizabeth s. eaton, Staff Writer Qiagen N.V. (NYSE:QGEN; Xetra:QIA) Chairman Håkan Björklund has stepped down, a week...
...company Xeris Pharmaceuticals Inc. (NASDAQ:XERS) has promoted COO John Shannon to president and COO. Elizabeth S. Eaton Qiagen N.V. Sanifit...

...By Biocentury staff Qiagen to remain independentQiagen N.V. (NYSE:QGEN; Xetra:QIA) said it terminated its agreement to...
...acquired by Thermo Fisher Scientific Inc. (NYSE:TMO) after only 47% of shares were tendered by Qiagen...
...diagnostics company for €39 ($43.33) per share, or about $11.5 billion (see “Thermo Fisher Takes out Qiagen”).Inhibrx, Harmony near...

...compare the nature of the lawsuits between Illumina and BGI and that between Illumina and Qiagen...
...BGI. Since 2012, Illumina has had an ongoing patent dispute with its largest European competitor, Qiagen N.V....
...compare the nature of the lawsuits between Illumina and BGI and that between Illumina and Qiagen...

...FDA’s emergency use authorization for a Qiagen test Tuesday comes amid a flurry of advancements in...
...GigaGen’s unveiling of a polyclonal antibody program derived from convalescent COVID-19 patients. The test from Qiagen N.V....
...choice. Further analysis of the coronavirus crisis can be found at https://www.biocentury.com/coronavirus . Sandi Wong, Assistant Editor Qiagen N.V. Becton...

...for €360 million in milestones. It also invested in Stat-Dx Life S.L., a diagnostics company Qiagen N.V....

...become the permanent CEO after serving on an interim basis since October. Bernard, who joined Qiagen...
...to provide diagnostic testing during the COVID-19 pandemic. Thermo Fisher Scientific Inc. (NYSE:TMO) is acquiring Qiagen...
...is retiring April 30. Reali was president and CEO of Clinical Innovations LLC. Robin Sawka, BioCentury Staff Qiagen N.V. CytomX...